{
    "clinical_study": {
        "@rank": "42128", 
        "arm_group": [
            {
                "arm_group_label": "ELAD", 
                "arm_group_type": "Experimental", 
                "description": "Treatment with ELAD, extracorporeal liver assist system and standard of care"
            }, 
            {
                "arm_group_label": "Standard of care (Control)", 
                "arm_group_type": "Other", 
                "description": "Standard of care for patients with fulminant hepatic (liver) failure"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if treatment with the ELAD Bioartificial Liver\n      Assist Device is beneficial to patients in Acute Liver Failure either as a bridge to liver\n      transplant or bridge to native liver recovery."
        }, 
        "brief_title": "Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure", 
        "completion_date": {
            "#text": "February 2003", 
            "@type": "Actual"
        }, 
        "condition": "Fulminant Hepatic Failure", 
        "condition_browse": {
            "mesh_term": [
                "Liver Failure", 
                "Liver Failure, Acute"
            ]
        }, 
        "detailed_description": {
            "textblock": "Current treatment with modalities in Acute Liver Failure still carry unacceptable morbidity\n      and mortality.  It is hoped that by intervening with ELAD a patient will have an opportunity\n      to be bridged to transplant or to avoid transplantation and to have their native liver\n      recover."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Clinical diagnosis of Fulminant Hepatic Failure with encephalopathy, and coagulopathy\n\n          -  Weight not less than 40 kilograms\n\n          -  Not listed for organ transplant, but no medical contraindications for transplant\n\n        Exclusion Criteria:\n\n          -  Listed for organ transplant at stud entry\n\n          -  History of jaundice for greater than 28 days at screening\n\n          -  Liver dysfunction due to trauma\n\n          -  Concomitant serious disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 11, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00030225", 
            "org_study_id": "CR-202"
        }, 
        "intervention": [
            {
                "arm_group_label": "ELAD", 
                "intervention_name": "ELAD", 
                "intervention_type": "Biological", 
                "other_name": "Extracorporeal Liver Assist Device"
            }, 
            {
                "arm_group_label": "Standard of care (Control)", 
                "intervention_name": "Standard of care (Control)", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Fulminant Hepatic Failure", 
        "lastchanged_date": "July 24, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "UCSD"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "University of Miami"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30322"
                    }, 
                    "name": "Emory School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "University of Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213"
                    }, 
                    "name": "University of Pittsburgh"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22908"
                    }, 
                    "name": "University of Virginia"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 2 Evaluation of the Vitagen Extracorporeal Liver Assist Device (ELAD) System in the Management of the Patients With Fulminant Hepatic Failure", 
        "overall_official": {
            "affiliation": "VitaGen", 
            "last_name": "Patrick J Maguire, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2003", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "30-day survival", 
            "measure": "Number of subjects reaching 30-Day survival", 
            "safety_issue": "Yes", 
            "time_frame": "Study Day 30"
        }, 
        "reference": {
            "citation": "Millis M, Maguire P, Cronin D, Conjeevarum H, Johnson R, Conlin C, Brotherton J, O'Laughlin R, Triglia D, Piazza R: Continuous Human Liver Support As A Bridge To Transplantation. Hepatology- Vol.30, No.4 October 1999 p168A."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00030225"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "30-day transplant-free survival", 
            "safety_issue": "Yes", 
            "time_frame": "Study Day 30"
        }, 
        "source": "Vital Therapies, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vital Therapies, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2002", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }, 
    "geocoordinates": {
        "Emory School of Medicine": "33.749 -84.388", 
        "Massachusetts General Hospital": "42.358 -71.06", 
        "UCSD": "32.715 -117.157", 
        "University of Chicago": "41.878 -87.63", 
        "University of Miami": "25.789 -80.226", 
        "University of Pittsburgh": "40.441 -79.996", 
        "University of Virginia": "38.029 -78.477"
    }
}